Aktienanalyse zu Bath & Body Works, Inc. (BBWI)BBWIBath & Body Works, Inc.

Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option. It operates in the Consumer Cyclicals sector (RETAIL-WOMEN'S CLOTHING STORES industry).

Bath & Body Works Inc is currently priced at $17.34, which is below the average analyst price target of $20. However, the company has reported a significant decline in sales, with a 2.3% year-over-year drop in Q2, despite improved profitability metrics such as an adjusted EPS of $0.62. The RSI is at 53.845, indicating a neutral momentum, while the forward P/E ratio is 6.27, suggesting the stock is undervalued relative to earnings expectations. The main risk is the ongoing sales decline, which is projected to continue, with a forecasted drop of 5% to 2.5% in Q3.